---

Clinical Trials

 For more studies in progress or recruiting see www.clinicaltrials.gov and enter keywords such as: neuroendocrine, islet cell, carcinoid, pancreatic neuroendocrine, paraganglioma, pheochromocytoma, etc.

Sample Current Clinical Trials Recruiting Participants

Natural History of Familial Carcinoid Tumor - NIH - Observational Study

An Investigation of Small Intestinal Carcinoid Carcinoma in Families - Retrospective Case Studies

An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome - Phase III

Safety and Efficacy of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease (LAR) - Phase III

Study Investigating MEN1 and SDHD in Familial Carcinoid Tumors - Observational Case Control, Prospective

Study of LX1606 in Subjects With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy - Phase II (Effective dose study)

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors - Phase I for carcinoid; Phase II for Islet cell, Lung Cancer, Neoplastic Syndrome, Neuroendocrine Carcinoma of the Skin

Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer - Phase II for Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Lung Cancer, Multiple Endocrine Neoplasia, Neoplastic Syndrome

Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors - Phase I for Colorectal Cancer, Gastrointestinal Carcinoid Tumor, Head and Neck Cancer, Islet Cell Tumor, Lung Cancer, Metastatic Cancer, Neuroendocrine Carcinoma of the Skin, Ovarian Cancer, Pheochromocytoma, Sarcoma, Unspecified Adult Solid Tumor, Protocol specific.

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer - Phase I

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors - Phase I

Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors - Treatment of Patients With Hepatic Neuroendocrine Metastases Using Drug-Eluting Bead Embolization

Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features - Phase I Dose-Escalation Study of Seneca Valley Virus (SVV-001), a Replication-Competent Picornavirus, in Patients With Advanced Solid Tumors With Neuroendocrine Features

Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors - Phase I - Som 230 & Rad 001

Multicenter Study of IMC-A12 in Combination With Depot Octreotide in Patients With Carcinoid or Islet Cell Cancer - Phase 2, Multicenter, Two Tier Study of IMC-A12 in Combination With Depot Octreotide in Patients With Metastatic, Well or Moderately Differentiated Carcinoid or Islet Cell Carcinoma

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma - Phase I Trial of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors - Phase I Study of Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors (Neuroendocrine Tumor, Carcinoid Tumor, Pancreatic Neuroendocrine Tumor

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain - Phase III - A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer - Phase II Study Of Hepatic Arterial Infusion Of Melphalan With Venous Filtration Via Peripheral Hepatic Perfusion (PHP) For Unresectable Primary And Metastatic Cancers Of The Liver

Erlotinib and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer - Phase I/II Clinical and Biological Evaluation of Combined EGFR Blockade With Erlotinib and Cetuximab in Patients With Advanced Cancer (Phase I) or Advanced Colorectal Cancer (Phase II)

Study of Sunitinib Malate Following Hepatic Artery Embolization - Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization for Metastatic Gastrointestinal Neuroendocrine Tumors - Neuroendocrine Tumor, Islet Cell Tumor

Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors - Phase II & III - High Dose Indium-111 Pentetreotide Therapy in Somatostatin Receptor Expressing Neuroendocrine Neoplasms.

For more studies in progress or recruiting see www.clinicaltrials.gov and enter keywords such as: neuroendocrine, islet cell, carcinoid, pancreatic neuroendocrine, paraganglioma, pheochromocytoma